Literature DB >> 3793925

Steroid-sensitive mechanism of soluble immune response suppressor production in steroid-responsive nephrotic syndrome.

H W Schnaper, T M Aune.   

Abstract

Soluble immune response suppressor (SIRS), a lymphokine that suppresses antibody production and delayed type hypersensitivity in vivo, has been detected in urine and serum from certain patients with nephrotic syndrome. In the present paper, the relationship between SIRS production and nephrotic syndrome is further characterized. A striking correlation was found between detection of SIRS and the presence of steroid-responsive nephrotic syndrome (SRNS). A potential mechanism of SIRS production in SRNS patients was identified, in that lymphocytes from patients produced SIRS without requiring activation by exogenous agents, and incubation of normal lymphocytes with serum from patients activated the cells to secrete SIRS in culture. Although SIRS disappears rapidly from urine or serum after initiation of corticosteroid therapy, hydrocortisone (10(-6)-10(-7) M) did not block secretion of SIRS by activated suppressor cells. It did, however, inhibit in vitro activation of lymphocytes to produce SIRS by concanavalin A, interferon, or SRNS patient serum. The association of suppressor cell activation with SRNS and the sensitivity of both to steroids suggest that the pathogeneses of albuminuria and SIRS production are related.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3793925      PMCID: PMC424035          DOI: 10.1172/JCI112792

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  20 in total

1.  Biological expressions of lymphocyte activation. 3. Suppression of plaque-forming cell responses in vitro by supernatant fluids from concanavalin A-activated spleen cell cultures.

Authors:  R R Rich; C W Pierce
Journal:  J Immunol       Date:  1974-04       Impact factor: 5.422

2.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

3.  A plaque assay for all cells secreting Ig of a given type or class.

Authors:  E Gronowicz; A Coutinho; F Melchers
Journal:  Eur J Immunol       Date:  1976-08       Impact factor: 5.532

4.  Activation of a suppressor T-cell pathway by interferon.

Authors:  T M Aune; C W Pierce
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

5.  Pathogenesis of lipoid nephrosis: a disorder of T-cell function.

Authors:  R J Shalhoub
Journal:  Lancet       Date:  1974-09-07       Impact factor: 79.321

6.  Inhibition of lymphocyte blastogenesis by plasma of patients with minimal-change nephrotic syndrome.

Authors:  A V Moorthy; S W Zimmerman; P M Burkholder
Journal:  Lancet       Date:  1976-05-29       Impact factor: 79.321

7.  Depression of endostreptosin, streptolysin O and streptozyme antibodies in patients with idiopathic nephrosis with and without a nephrotic syndrome.

Authors:  K Lange; U Ahmed; G Seligson; A Grover
Journal:  Clin Nephrol       Date:  1981-06       Impact factor: 0.975

8.  Conversion of soluble immune response suppressor to macrophage-derived suppressor factor by peroxide.

Authors:  T M Aune; C W Pierce
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

9.  T-cell dysfunction in minimal-change nephrotic syndrome of childhood.

Authors:  P Fodor; M T Saitúa; E Rodriguez; B González; L Schlesinger
Journal:  Am J Dis Child       Date:  1982-08

10.  Serum immunoglobulins in the nephrotic syndrome. A possible cause of minimal-change nephrotic syndrome.

Authors:  J Giangiacomo; T G Cleary; B R Cole; P Hoffsten; A M Robson
Journal:  N Engl J Med       Date:  1975-07-03       Impact factor: 91.245

View more
  8 in total

1.  Familial steroid-sensitive nephrotic syndrome in Southern Israel: clinical and genetic observations.

Authors:  Daniel Landau; Tal Oved; Dan Geiger; Luba Abizov; Hanna Shalev; Ruti Parvari
Journal:  Pediatr Nephrol       Date:  2007-01-12       Impact factor: 3.714

Review 2.  Do circulating factors play a role in the pathogenesis of minimal change nephrotic syndrome?

Authors:  W W Bakker; W H van Luijk
Journal:  Pediatr Nephrol       Date:  1989-07       Impact factor: 3.714

Review 3.  The immune system in minimal change nephrotic syndrome.

Authors:  H W Schnaper
Journal:  Pediatr Nephrol       Date:  1989-01       Impact factor: 3.714

Review 4.  Management of nephrotic syndrome in childhood.

Authors:  T Melvin; W Bennett
Journal:  Drugs       Date:  1991-07       Impact factor: 9.546

5.  Altered expression of glomerular heat shock protein 27 in experimental nephrotic syndrome.

Authors:  W E Smoyer; A Gupta; P Mundel; J D Ballew; M J Welsh
Journal:  J Clin Invest       Date:  1996-06-15       Impact factor: 14.808

6.  Major histocompatibility complex antigens in steroid-responsive nephrotic syndrome.

Authors:  P T McEnery; T R Welch
Journal:  Pediatr Nephrol       Date:  1989-01       Impact factor: 3.714

7.  Childhood nephrotic syndrome in relapse is associated with down-regulation of monocyte CD14 expression and lipopolysaccharide-induced tumour necrosis factor-alpha production.

Authors:  S P Chen; W Cheung; C K Heng; S C Jordan; H K Yap
Journal:  Clin Exp Immunol       Date:  2003-10       Impact factor: 4.330

8.  Normal splenic function in children with the nephrotic syndrome.

Authors:  J S Berns; H A Pearson; K M Gaudio; B McDonald; L Krassner; F Anderson; D Durante; N J Siegel
Journal:  Pediatr Nephrol       Date:  1988-04       Impact factor: 3.714

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.